These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 19652275)
1. The cellular uptake of meta-tetra(hydroxyphenyl)chlorin entrapped in organically modified silica nanoparticles is mediated by serum proteins. Compagnin C; Baù L; Mognato M; Celotti L; Miotto G; Arduini M; Moret F; Fede C; Selvestrel F; Rio Echevarria IM; Mancin F; Reddi E Nanotechnology; 2009 Aug; 20(34):345101. PubMed ID: 19652275 [TBL] [Abstract][Full Text] [Related]
2. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells. Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401 [TBL] [Abstract][Full Text] [Related]
3. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244 [TBL] [Abstract][Full Text] [Related]
4. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines. Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells. Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920 [TBL] [Abstract][Full Text] [Related]
6. Photophysical evaluation of mTHPC-loaded HSA nanoparticles as novel PDT delivery systems. Chen K; Wacker M; Hackbarth S; Ludwig C; Langer K; Röder B J Photochem Photobiol B; 2010 Dec; 101(3):340-7. PubMed ID: 20813540 [TBL] [Abstract][Full Text] [Related]
7. Photosensitizer loaded HSA nanoparticles. I: Preparation and photophysical properties. Wacker M; Chen K; Preuss A; Possemeyer K; Roeder B; Langer K Int J Pharm; 2010 Jun; 393(1-2):253-62. PubMed ID: 20417701 [TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
9. Comparative sensitivity of microvascular endothelial cells, fibroblasts and tumor cells after in vitro photodynamic therapy with meso-tetra-hydroxyphenyl-chlorin. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2004; 80(2):236-41. PubMed ID: 15362947 [TBL] [Abstract][Full Text] [Related]
10. Characterization of photodegradation of meta-tetra(hydroxyphenyl)chlorin (mTHPC) in solution: biological consequences in human tumor cells. Belitchenko I; Melnikova V; Bezdetnaya L; Rezzoug H; Merlin JL; Potapenko A; Guillemin F Photochem Photobiol; 1998 May; 67(5):584-90. PubMed ID: 9613242 [TBL] [Abstract][Full Text] [Related]
11. Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Dysart JS; Singh G; Patterson MS Photochem Photobiol; 2005; 81(1):196-205. PubMed ID: 15469385 [TBL] [Abstract][Full Text] [Related]
12. Effect of the TAT-RasGAP(317-326) peptide on apoptosis of human malignant mesothelioma cells and fibroblasts exposed to meso-tetra-hydroxyphenyl-chlorin and light. Pittet O; Petermann D; Michod D; Krueger T; Cheng C; Ris HB; Widmann C J Photochem Photobiol B; 2007 Jul; 88(1):29-35. PubMed ID: 17560792 [TBL] [Abstract][Full Text] [Related]
13. Interaction of liposomal formulations of meta-tetra(hydroxyphenyl)chlorin (temoporfin) with serum proteins: protein binding and liposome destruction. Reshetov V; Zorin V; Siupa A; D'Hallewin MA; Guillemin F; Bezdetnaya L Photochem Photobiol; 2012; 88(5):1256-64. PubMed ID: 22607362 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasma and individualized light dosimetry in photodynamic therapy. Glanzmann T; Hadjur C; Zellweger M; Grosiean P; Forrer M; Ballini JP; Monnier P; van den Bergh H; Lim CK; Wagnières G Photochem Photobiol; 1998 May; 67(5):596-602. PubMed ID: 9613244 [TBL] [Abstract][Full Text] [Related]
16. Outcome of mTHPC mediated photodynamic therapy is primarily determined by the vascular response. Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA Photochem Photobiol; 2005; 81(5):1161-7. PubMed ID: 15934792 [TBL] [Abstract][Full Text] [Related]
17. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. Sant S; Poulin S; Hildgen P J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men. Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028 [TBL] [Abstract][Full Text] [Related]
20. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases. Wennink JWH; Liu Y; Mäkinen PI; Setaro F; de la Escosura A; Bourajjaj M; Lappalainen JP; Holappa LP; van den Dikkenberg JB; Al Fartousi M; Trohopoulos PN; Ylä-Herttuala S; Torres T; Hennink WE; van Nostrum CF Eur J Pharm Sci; 2017 Sep; 107():112-125. PubMed ID: 28679107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]